AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Meglipride M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

LifeCare Formulation Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Meglipride M 1mg/500mg Tablet

Diabex Duo 1mg/500mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, incorporating a balanced diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential for prevention. Alcohol consumption should be limited due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor prior to use during pregnancy or breastfeeding. Regular blood glucose monitoring is necessary, along with potential blood tests to track blood cell counts and liver function.

Uses of Meglipride M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Meglipride M 1mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Meglipride M 1mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Meglipride M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Meglipride M 1mg/500mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Meglipride M 1mg/500mg tablets with food.

How Meglipride M 1mg/500mg Tablet works:

Meglipride M, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Meglipride M 1mg/500mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Meglipride M 1mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingUNSAFE

Use of Meglipride M 1mg/500mg tablets while breastfeeding is contraindicated due to potential infant toxicity. Evidence indicates a risk of harmful effects to the nursing infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Meglipride M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Meglipride M 1mg/500mg tablets. Physician consultation is recommended. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Meglipride M 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Meglipride M 1mg/500mg Tablet :

Should you forget to take your Meglipride M 1mg/500mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Meglipride M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Meglipride M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Meglipride M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels. Also known as MALA (Metformin-associated lactic acidosis), this rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Meglipride M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Meglipride M 1mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of Meglipride M 1mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Meglipride M 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Meglipride M 1mg/500mg tablets and alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Meglipride M 1mg/500mg Ta...
41
MRP 48
14% off